NO990300D0 - <Alfa>-aminosyreamider, fremstilling og terapeutisk anvendelse derav - Google Patents

<Alfa>-aminosyreamider, fremstilling og terapeutisk anvendelse derav

Info

Publication number
NO990300D0
NO990300D0 NO990300A NO990300A NO990300D0 NO 990300 D0 NO990300 D0 NO 990300D0 NO 990300 A NO990300 A NO 990300A NO 990300 A NO990300 A NO 990300A NO 990300 D0 NO990300 D0 NO 990300D0
Authority
NO
Norway
Prior art keywords
alpha
preparation
amino acid
acid amides
therapeutic use
Prior art date
Application number
NO990300A
Other languages
English (en)
Other versions
NO990300L (no
NO326826B3 (no
NO326826B1 (no
Inventor
Paolo Chiesi
Paolo Ventura
Maurizio Delcanale
Renato De Fanti
Elisabetta Armani
Gino Viletti
Claudio Pietra
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO990300L publication Critical patent/NO990300L/no
Publication of NO990300D0 publication Critical patent/NO990300D0/no
Publication of NO326826B1 publication Critical patent/NO326826B1/no
Publication of NO326826B3 publication Critical patent/NO326826B3/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19990300A 1996-07-23 1999-01-22 Alfa-aminosyreamider, fremstilling og terapeutisk anvendelse derav NO326826B3 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI001544A IT1283489B1 (it) 1996-07-23 1996-07-23 Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
PCT/EP1997/003773 WO1998003472A1 (en) 1996-07-23 1997-07-15 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof

Publications (4)

Publication Number Publication Date
NO990300L NO990300L (no) 1999-01-22
NO990300D0 true NO990300D0 (no) 1999-01-22
NO326826B1 NO326826B1 (no) 2009-02-23
NO326826B3 NO326826B3 (no) 2010-06-07

Family

ID=11374651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990300A NO326826B3 (no) 1996-07-23 1999-01-22 Alfa-aminosyreamider, fremstilling og terapeutisk anvendelse derav

Country Status (26)

Country Link
US (1) US6114391A (no)
EP (1) EP0951465B1 (no)
JP (1) JP4542208B2 (no)
CN (1) CN1211351C (no)
AR (1) AR007963A1 (no)
AT (1) ATE237584T1 (no)
AU (1) AU729176B2 (no)
CA (1) CA2261259C (no)
CZ (1) CZ295824B6 (no)
DE (1) DE69721052T2 (no)
DK (1) DK0951465T3 (no)
ES (1) ES2195158T3 (no)
HU (1) HU225623B1 (no)
ID (1) ID17999A (no)
IL (1) IL128020A (no)
IT (1) IT1283489B1 (no)
MY (1) MY118244A (no)
NO (1) NO326826B3 (no)
NZ (1) NZ333869A (no)
PT (1) PT951465E (no)
RU (1) RU2174511C2 (no)
SI (1) SI0951465T1 (no)
TR (1) TR199900087T2 (no)
TW (1) TW557291B (no)
WO (1) WO1998003472A1 (no)
ZA (1) ZA976479B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672746A (en) 1994-08-30 1997-09-30 American Biogenetic Sciences, Inc. Antiproliferative and neurotrophic molecules
PL345364A1 (en) 1998-06-22 2001-12-17 American Biogenetic Sciences The use of valproic acid analog for the treatment and prevention of migraine and affective illness
US20030035784A1 (en) 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
ES2270947T3 (es) * 2001-12-21 2007-04-16 Chiesi Farmaceutici S.P.A. Derivados de 2-indanilamino para la terapia de dolor cronico, agudo o inflamatorio.
FR2843590B1 (fr) * 2002-08-14 2007-10-05 Prestwick Scient Capital Inc Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
US20040082543A1 (en) * 2002-10-29 2004-04-29 Pharmacia Corporation Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
WO2006016219A2 (en) * 2004-08-03 2006-02-16 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
US9475757B2 (en) 2013-05-03 2016-10-25 Council Of Scientific & Industrial Research Synthesis of anti-Parkinson agent
CN105646252A (zh) * 2016-02-25 2016-06-08 吉尔生化（上海）有限公司 一种丝氨酸酰胺盐酸盐的合成方法
CN114051496B (zh) * 2019-06-25 2023-08-04 阿米蒂比奥有限公司 将联苯基引入新型氨基烷酸的衍生物化合物及包含其的抗真菌药学组合物
CA3218884A1 (en) * 2021-05-11 2022-11-17 David Nutt Therapeutic aminoindane compounds and compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3050800C2 (no) * 1979-03-22 1989-06-22 Continental Pharma Inc., Bruessel/Bruxelles, Be
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
EP0333154B1 (en) * 1988-03-16 1997-07-16 Eisai Co., Ltd. Process for the preparation of cephem derivatives
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5198547A (en) * 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
US5332840A (en) * 1993-05-27 1994-07-26 Bristol-Myers Squibb Company Method for preparing a benzaldehyde intermediate

Also Published As

Publication number Publication date
JP4542208B2 (ja) 2010-09-08
NO990300L (no) 1999-01-22
NO326826B3 (no) 2010-06-07
CZ295824B6 (cs) 2005-11-16
CN1211351C (zh) 2005-07-20
NO326826B1 (no) 2009-02-23
HU225623B1 (en) 2007-05-02
PT951465E (pt) 2003-08-29
ITMI961544A1 (it) 1998-01-23
EP0951465B1 (en) 2003-04-16
AR007963A1 (es) 1999-11-24
AU3695297A (en) 1998-02-10
IT1283489B1 (it) 1998-04-21
ES2195158T3 (es) 2003-12-01
CZ18299A3 (cs) 1999-06-16
CA2261259A1 (en) 1998-01-29
MY118244A (en) 2004-09-30
IL128020A (en) 2002-04-21
ATE237584T1 (de) 2003-05-15
US6114391A (en) 2000-09-05
TR199900087T2 (xx) 1999-03-22
IL128020A0 (en) 1999-11-30
SI0951465T1 (en) 2003-08-31
EP0951465A1 (en) 1999-10-27
JP2001506577A (ja) 2001-05-22
AU729176B2 (en) 2001-01-25
CA2261259C (en) 2006-10-03
DE69721052T2 (de) 2004-02-05
RU2174511C2 (ru) 2001-10-10
NZ333869A (en) 2000-05-26
ITMI961544A0 (no) 1996-07-23
WO1998003472A1 (en) 1998-01-29
TW557291B (en) 2003-10-11
ID17999A (id) 1998-02-19
DK0951465T3 (da) 2003-08-11
ZA976479B (en) 1998-03-02
HUP9902992A3 (en) 2004-04-28
DE69721052D1 (de) 2003-05-22
CN1225625A (zh) 1999-08-11

Similar Documents

Publication Publication Date Title
NO307335B1 (no) Substituerte N-(indol-2-karbonyl)-&lt;beta&gt;-alaninamider, anvendelse derav og farmasøytisk preparat
NO306398B1 (no) Substituerte N-(indol-2-karbonyl) glycinamider, anvendelse derav, mellomprodukt og farmasöytisk preparat
NO993619D0 (no) Titandioksid, fremstilling og anvendelse derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20012245D0 (no) Anthranilsyreamider og anvendelse derav som medikamenter
NO975513D0 (no) 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel
HUP0103793A3 (en) N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO984209D0 (no) Syretolerant kalsiumkarbonatblanding og anvendelse derav
NO990300L (no) &lt;Alfa&gt;-aminosyreamider, fremstilling og terapeutisk anvendelse derav
NO962477D0 (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
DK51789D0 (da) Aminosyreamider, deres fremstilling og anvendelse
EP1194548A4 (en) NOVEL PYRRHOCORICIN-DERIVED PEPTIDES AND METHODS OF IMPLEMENTING THE SAME
NO20023015D0 (no) Humant heparanasebeslektet polypeptid og nukleinsyre
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
DE69912315D1 (de) ((aminoiminomethyl)amino) alkanecarboxamide und deren therapeutische verwendungen
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
NO990303D0 (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
NO955325D0 (no) Propansyrederivater, deres fremstilling og terapeutiske anvendelse
IS4349A (is) Meðferðavirk amíð og notkun þeirra
NO981089D0 (no) Epoksy-azetidinoner, fremstilling og anvendelse derav
DE69434900D1 (de) Menschliche chemokin-polypeptide
SE9802562D0 (sv) New peptides and use thereof
SE9802441D0 (sv) New peptides and use thereof

Legal Events

Date Code Title Description
LC4 Limitation of patent rights - b3 (par. 39b patent act)

Effective date: 20100607

MM1K Lapsed by not paying the annual fees